AfterRaise/Companies/Infinimmune

Infinimmune

USAAlamedaBiotech & PharmaSeries A

Overview

Where Infinimmune is now

Infinimmune announced a Series A round of $75M on 12 August 2026, led by Regeneron Ventures and Playground Global.

Observed Described in the funding announcement as "biotechnology company developing antibody therapeutics derived directly from the human immune system". Source

Latest round
Series A
Amount
$75M
Announced
12 August 2026
Headquarters
Alameda, USA
Sector
Biotech & Pharma
Investors
Regeneron Ventures and Playground Global
Also participating
RA Capital Management, Goldcrest Capital, Forge Life Science Partners, Godfrey Capital, Wild Tree Ventures, Merck Global Health Innovation Fund, Everbright Biofund, Civilization Ventures, and Pear VC
Relevant leadership
Co-Founder and CEO Wyatt McDonnell

Current direction Inferred

What this company is working on

ProductResearch and developmentInfrastructure

Read from the company's own description of what the funding supports.

Momentum Inferred

AfterRaise Score

74
Building momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
19/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 12 August 2026
    $75M Series A
    Led by Regeneron Ventures and Playground Global.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Infinimmune from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Infinimmune

Not yet specified

Infinimmune has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Infinimmune.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector